Overview
Financials
Revenue history
From the notes
| Profit allocation | Loss to be covered | |
| Loans and borrowings | $103,711 | |
| Events after the balance sheet date | Yes |
Filing timeliness
1 of 2 financial statements was filed late (for 2025, 107 days late).
- 202530/10/2026
- 202411/07/2025
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Authorized Representatives
Manner of representation
In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Hong Nguyen Thi Maiage 64 | 10 | $135.06 | 10% |
Linh Ziółkowskaage 39 | 90 | $1,215.56 | 90% |
The articles of association require board approval for share transfers.
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Fungotechsp. z o.o. | $187.68 | fungo.tech | ||
| Biophage PharmaS.A. | $172.36 | biophagepharma.pl | ||
| Ncage TherapeuticsS.A. | $29.14 | ncage.org |
Change history
| Date | Event | |
|---|---|---|
| 2026-05-01 | Business suspended | |
| 2024-05-17 | Entered in the register |
FAQ
Last updated: 2026-10-30